In a Sign o’ the Times, Sanofi-Aventis and Bristol-Myers Squibb have reached a settlement agreement with Apotex in the patent infringement lawsuit pending between the parties in the US District Court. The suit relates to the validity of a composition of matter patent for clopidogrel bisulfate, the active ingredient in Plavix. Plavix is one of […]